Sign Up Today and Learn More About Estimize Stock
Invest in or calculate the value of your shares in Estimize or other pre-IPO companies through EquityZen's platform.
Estimize Stock
Financial estimates using aggregation from independent analysts
About Estimize Stock
Founded
2011
Total Funding
12.2M
Industries
Messaging and Telecommunications, Sports, Content and Publishing
Estimize is an open financial estimates platform which facilitates the aggregation of fundamental estimates from independent, buy-side, and sell-side analysts, along with those of private investors and students. Estimize has over 5149 analysts’ contributors, resulting in coverage on over 900 stocks each quarter. The firm was founded in 2011 by former quantitative hedge fund analyst Leigh Drogen, with the belief that the financial ecosystem was ready for an estimates platform built with an open and transparent philosophy. The Estimize consensus estimate is regularly referenced in notable financial media sources such as Forbes, Barron’s, The Wall Street Journal, CNN Money, The Street, Investor’s Business Daily and Business Week, amongst others. Estimize data is now available on major financial research platforms such as Bloomberg.
Estimize Press Mentions
Stay in the know about the latest news on Estimize
Get Involved in the Competition CNBC Dubbed "Fantasy Sports for Stocks" - Estimize Introduces Forcerank
• Mar 10, 2016
Twitter 'bloodbath' will end soon
• Feb 10, 2016
Forbes Adds Seven FinTech Sandbox Members to Fintech 50 List of 2015
• Dec 17, 2015
How Investors Are Using Social Media to Make Money
• Dec 07, 2015
The Republicans and CNBC
• Nov 01, 2015
Estimize Management
Leadership team at Estimize
Co-Founder and CEO
Leigh Drogen
Chief Technology Officer
Brian Smith
Join now and verify your accreditation status to gain access to:
- Estimize Current Valuation
- Estimize Stock Price
- Estimize Management
- Available deals in Estimize and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Estimize Cap Table and Funding History by Share Class and Liquidity Preferences
- Estimize Revenue and Financials
- Estimize Highlights
- Estimize Business Model
- Estimize Risk Factors
- Estimize Research Report from SACRA Research
Trading Estimize Stock
How to invest in Estimize stock?
Accredited investors can buy pre-IPO stock in companies like Estimize through EquityZen funds. These investments are made available by existing Estimize shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Estimize stock?
Shareholders can sell their Estimize stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."